Document:

Exhibit 4.4

 

Warrant No. 2016-A-___

 

NEITHER THE WARRANT NOR THE SHARES ISSUABLE
UPON EXERCISE OF THE WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR UNDER THE SECURITIES LAWS OF ANY STATES. THE WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THE WARRANT ARE SUBJECT TO RESTRICTIONS
ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND THE APPLICABLE
STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM, OR OTHERWISE SET FORTH IN A SECURITIES PURCHASE AGREEMENT
DATED AS OF APRIL __, 2016. UNLESS SOLD PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, THE ISSUER OF
THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT REGISTRATION
IS NOT REQUIRED UNDER THE SECURITIES ACT.

 

Right to 

Purchase [    ]

 Shares of

 Common 

Stock, par

value $.0001

 per share

 

STOCK PURCHASE WARRANT

 

THIS CERTIFIES THAT, for value received,
[   ] (the “Holder”) or its registered assigns, is entitled to purchase from ID Global Solutions Corporation,
a Delaware corporation (the “Company”), at any time or from time to time during the period specified in Paragraph 2
hereof, [such number of shares of common stock equal to the conversion shares]
fully paid and nonassessable shares of the Company’s Common Stock, par value $.0001 per share (the “Common Stock”),
at an exercise price per share equal to $0.25 (the “Exercise Price”). The term “Warrant Shares,” as used
herein, refers to the shares of Common Stock purchasable hereunder. The Warrant Shares and the Exercise Price are subject to adjustment
as provided in Paragraph 4 hereof. The term “Warrants” means this Warrant and the other warrants issued pursuant to
that certain Securities Purchase Agreement, dated April __, 2016, by and among the Company and the Buyers listed on the execution
page thereof (the “Securities Purchase Agreement”).

 

This Warrant is subject to the following
terms, provisions, and conditions:

 

     

     

    

 

1.          Manner
of Exercise; Issuance of Certificates; Payment for Shares. Subject to the provisions hereof,
this Warrant may be exercised by the Holder, in whole or in part, by the surrender of this Warrant, together with a completed exercise
agreement in the form attached hereto (the “Exercise Agreement”), to the Company during normal business hours on any
business day at the Company’s principal executive offices (or such other office or agency of the Company as it may designate
by notice to the Holder), and upon payment to the Company in cash, by certified or official bank check or by wire transfer for
the account of the Company of the Exercise Price for the Warrant Shares specified in the Exercise Agreement. The Warrant Shares
so purchased shall be deemed to be issued to the Holder or such Holder’s designee, as the record owner of such shares, as
of the close of business on the date on which this Warrant shall have been surrendered, the completed Exercise Agreement shall
have been delivered, and payment shall have been made for such shares as set forth above. Certificates for the Warrant Shares so
purchased, representing the aggregate number of shares specified in the Exercise Agreement, shall be delivered to the Holder within
a reasonable time, not exceeding three (3) business days, after this Warrant shall have been so exercised. If this Warrant shall
have been exercised only in part, then, unless this Warrant has expired, the Company shall, at its expense, at the time of delivery
of such certificates, deliver to the Holder a new Warrant representing the number of shares with respect to which this Warrant
shall not then have been exercised. 

 

If at any time on or after the six month anniversary
of the date of this Warrant there is no Form S-1 Registration Statement effective and available for use by the Holder to resell
the Warrant Shares immediately upon exercise of this Warrant, this Warrant may also be exercised, in whole or in part, at such
time by means of a “cashless exercise” in which the Holder shall be entitled to receive a certificate for the number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) = the average VWAP on the thirty
(30) Trading Days immediately preceding the date on which Holder elects to exercise this Warrant by means of a “cashless
exercise,” as set forth in the applicable Notice of Exercise;

 

(B) = the Exercise Price of this
Warrant, as adjusted hereunder; and

 

(X) = the number of Warrant
Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.

 

Notwithstanding anything in this Warrant to
the contrary, in no event shall the Holder be entitled to exercise a number of Warrants (or portions thereof) in excess of the
number of Warrants (or portions thereof) upon exercise of which the sum of (i) the number of shares of Common Stock beneficially
owned by the Holder and its affiliates (other than shares of Common Stock which may be deemed beneficially owned through the ownership
of the unexercised Warrants and the unexercised or unconverted portion of any other securities of the Company (including the Notes
(as defined in the Securities Purchase Agreement)) subject to a limitation on conversion or exercise analogous to the limitation
contained herein) and (ii) the number of shares of Common Stock issuable upon exercise of the Warrants (or portions thereof) with
respect to which the determination described herein is being made, would result in beneficial ownership by the Holder and its affiliates
of more than 4.9% of the outstanding shares of Common Stock. For purposes of the immediately preceding sentence, beneficial ownership
shall be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and Regulation 13D-G thereunder,
except as otherwise provided in clause (i) of the preceding sentence. Notwithstanding anything to the contrary contained herein,
the limitation on exercise of this Warrant set forth herein may not be amended without (i) the written consent of the Holder and
the Company and (ii) the approval of a majority of shareholders of the Company.

 

    	 	2	 

     

    

 

2.          Period
of Exercise.   This Warrant is exercisable
at any time or from time to time on or after the date on which this Warrant is issued and delivered pursuant to the terms of the
Securities Purchase Agreement and before 6:00 p.m., New York, New York time on the fifth (5th) anniversary of the date of issuance
(the “Exercise Period”). 

 

3.           Certain
Agreements of the Company.          The Company hereby covenants and agrees
as follows:

 

(a)          Shares
to be Fully Paid. All Warrant Shares will, upon issuance in accordance with the terms of this Warrant, be validly issued,
fully paid, and nonassessable and free from all taxes, liens, and charges with respect to the issue thereof.

 

(b)          Reservation
of Shares. During the Exercise Period, the Company shall at all times have authorized, and reserved for the purpose of
issuance upon exercise of this Warrant, a sufficient number of shares of Common Stock to provide for the exercise of this Warrant.

 

(c)          Successors
and Assigns. This Warrant will be binding upon any entity succeeding to the Company by merger, consolidation, or acquisition
of all or substantially all the Company’s assets.

 

4.           Antidilution
Provisions.   During the Exercise Period, the Exercise Price and the number of Warrant Shares
shall be subject to adjustment from time to time as provided in this Paragraph 4.

 

In the event that any adjustment of the
Exercise Price as required herein results in a fraction of a cent, such Exercise Price shall be rounded up to the nearest cent.

 

(a)          Adjustment
of Exercise Price and Number of Shares upon Closing of an Equity Financing Issuance of Common Stock. Except as otherwise
provided, upon the closing of any financing in which the Company sells shares of common stock or securities that are convertible
into common stock for gross proceeds in excess of $5,000,000 (the "Equity Financing"), then the Warrant Shares shall
be adjusted to equal the Purchase Price (as defined in the Securities Purchase Agreement) divided by the conversion price or the
per share purchase price (the "Equity Financing Price"). Further, the Exercise Price shall be adjusted to equal the Equity
financing Price. This adjustment shall occur one time only. Notwithstanding the foregoing, the Exercise Price will not be reduced
below $0.01 or above $0.25 per share.

 

(b)          Subdivision
or Combination of Common Stock. If the Company at any time subdivides (by any stock split, stock dividend, recapitalization,
reorganization, reclassification or otherwise) the shares of Common Stock acquirable hereunder into a greater number of shares,
then, after the date of record for effecting such subdivision, the Exercise Price in effect immediately prior to such subdivision
will be proportionately reduced. If the Company at any time combines (by reverse stock split, recapitalization, reorganization,
reclassification or otherwise) the shares of Common Stock acquirable hereunder into a smaller number of shares, then, after the
date of record for effecting such combination, the Exercise Price in effect immediately prior to such combination will be proportionately
increased.

 

    	 	3	 

     

    

 

(c)          Adjustment
in Number of Shares. Upon each adjustment of the Exercise Price pursuant to the provisions of this Paragraph 4(b), the
number of shares of Common Stock issuable upon exercise of this Warrant shall be adjusted by multiplying a number equal to the
Exercise Price in effect immediately prior to such adjustment by the number of shares of Common Stock issuable upon exercise of
this Warrant immediately prior to such adjustment and dividing the product so obtained by the adjusted Exercise Price.

 

(d)          Consolidation,
Merger or Sale. In case of any consolidation of the Company with, or merger of the Company into any other corporation,
or in case of any sale or conveyance of all or substantially all of the assets of the Company other than in connection with a plan
of complete liquidation of the Company, then as a condition of such consolidation, merger or sale or conveyance, adequate provision
will be made whereby the Holder will have the right to acquire and receive upon exercise of this Warrant in lieu of the shares
of Common Stock immediately theretofore acquirable upon the exercise of this Warrant, such shares of stock, securities or assets
as may be issued or payable with respect to or in exchange for the number of shares of Common Stock immediately theretofore acquirable
and receivable upon exercise of this Warrant had such consolidation, merger or sale or conveyance not taken place. In any such
case, the Company will make appropriate provision to insure that the provisions of this Paragraph 4 hereof will thereafter be applicable
as nearly as may be in relation to any shares of stock or securities thereafter deliverable upon the exercise of this Warrant.
The Company will not effect any consolidation, merger or sale or conveyance unless prior to the consummation thereof, the successor
corporation (if other than the Company) assumes by written instrument the obligations under this Paragraph 4 and the obligations
to deliver to the Holder such shares of stock, securities or assets as, in accordance with the foregoing provisions, the Holder
may be entitled to acquire.

 

5.          Issue
Tax. The issuance of certificates for Warrant Shares upon the exercise of this Warrant
shall be made without charge to the Holder or such shares for any issuance tax or other costs in respect thereof, provided that
the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery
of any certificate in a name other than the Holder.

 

6.          No
Rights or Liabilities as a Shareholder. This Warrant shall not entitle the Holder to any
voting rights or other rights as a shareholder of the Company. No provision of this Warrant, in the absence of affirmative action
by the Holder to purchase Warrant Shares, and no mere enumeration herein of the rights or privileges of the Holder, shall give
rise to any liability of such Holder for the Exercise Price or as a shareholder of the Company, whether such liability is asserted
by the Company or by creditors of the Company.

 

7.           Transfer,
Exchange, and Replacement of Warrant.

 

(a)          Restriction
on Transfer. This Warrant and the rights granted to the Holder are transferable, in whole or in part, upon surrender of
this Warrant, together with a properly executed assignment in the form attached hereto, at the office or agency of the Company,
provided, however, that any transfer or assignment shall be subject to the conditions set forth in Paragraph 7(f) hereof and to
the applicable provisions of the Securities Purchase Agreement. Until due presentment for registration of transfer on the books
of the Company, the Company may treat the registered Holder as the owner and holder of this Warrant for all purposes, and the Company
shall not be affected by any notice to the contrary.

 

    	 	4	 

     

    

 

(b)          Warrant
Exchangeable for Different Denominations. This Warrant is exchangeable, upon the surrender hereof by the Holder at the
office or agency of the Company, for new Warrants of like tenor representing in the aggregate the right to purchase the number
of shares of Common Stock which may be purchased hereunder, each of such new Warrants to represent the right to purchase such number
of shares as shall be designated by the Holder at the time of such surrender.

 

(c)          Replacement
of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction, or mutilation
of this Warrant and, in the case of any such loss, theft, or destruction, upon delivery of an indemnity agreement reasonably satisfactory
in form and amount to the Company, or, in the case of any such mutilation, upon surrender and cancellation of this Warrant, the
Company, at its expense, will execute and deliver, in lieu thereof, a new Warrant of like tenor.

 

(d)          Cancellation;
Payment of Expenses. Upon the surrender of this Warrant in connection with any transfer, exchange, or replacement as provided
in this Paragraph 7, this Warrant shall be promptly canceled by the Company. The Company shall pay all taxes (other than securities
transfer taxes) and all other expenses (other than legal expenses, if any, incurred by the Holder or transferees) and charges payable
in connection with the preparation, execution, and delivery of Warrants pursuant to this Paragraph 7.

 

(e)          Register.
The Company shall maintain, at its principal executive offices (or such other office or agency of the Company as it may designate
by notice to the Holder), a register for this Warrant, in which the Company shall record the name and address of the person in
whose name this Warrant has been issued, as well as the name and address of each transferee and each prior owner of this Warrant.

 

(f)          Exercise
or Transfer Without Registration. If, at the time of the surrender of this Warrant in connection with any exercise, transfer,
or exchange of this Warrant, this Warrant (or, in the case of any exercise, the Warrant Shares issuable hereunder), shall not be
registered under the Securities Act of 1933, as amended (the “Securities Act”) and under applicable state securities
or blue sky laws, the Company may require, as a condition of allowing such exercise, transfer, or exchange, (i) that the Holder
or transferee of this Warrant, as the case may be, furnish to the Company a written opinion of counsel, which opinion and counsel
are acceptable to the Company, to the effect that such exercise, transfer, or exchange may be made without registration under said
Act and under applicable state securities or blue sky laws, (ii) that the Holder or transferee execute and deliver to the Company
an investment letter in form and substance acceptable to the Company and (iii) that the transferee be an “accredited investor”
as defined in Rule 501(a) promulgated under the Securities Act; provided that no such opinion, letter or status as an “accredited
investor” shall be required in connection with a transfer pursuant to Rule 144 under the Securities Act. The first holder
of this Warrant, by taking and holding the same, represents to the Company that such holder is acquiring this Warrant for investment
and not with a view to the distribution thereof. In no event shall the Holder be permitted to assign the Warrant unless provided
with express written consent by the Company.

 

8.          [Intentionally
Omitted]

 

 

    	 	5	 

     

    

 

9.          Notices.
         All notices, requests, and other
communications required or permitted to be given or delivered hereunder to the Holder shall be in writing, and shall be personally
delivered, or shall be sent by certified or registered mail or by recognized overnight mail courier, postage prepaid and addressed,
to such holder at the address shown for such holder on the books of the Company, or at such other address as shall have been furnished
to the Company by notice from such holder. All notices, requests, and other communications required or permitted to be given or
delivered hereunder to the Company shall be in writing, and shall be personally delivered, or shall be sent by certified or registered
mail or by recognized overnight mail courier, postage prepaid and addressed, to the office of the Company at the address set forth
in the Purchase Agreement, or at such other address as shall have been furnished to the Holder by notice from the Company. Any
such notice, request, or other communication may be sent by facsimile, but shall in such case be subsequently confirmed by a writing
personally delivered or sent by certified or registered mail or by recognized overnight mail courier as provided above. All notices,
requests, and other communications shall be deemed to have been given either at the time of the receipt thereof by the person entitled
to receive such notice at the address of such person for purposes of this Paragraph 9, or, if mailed by registered or certified
mail or with a recognized overnight mail courier upon deposit with the United States Post Office or such overnight mail courier,
if postage is prepaid and the mailing is properly addressed, as the case may be.

 

10.         Governing
Law.          
THIS WARRANT SHALL BE ENFORCED, GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF FLORIDA APPLICABLE TO AGREEMENTS
MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE, WITHOUT REGARD TO THE PRINCIPLES OF CONFLICT OF LAWS. THE PARTIES HERETO HEREBY
SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE UNITED STATES FEDERAL COURTS LOCATED IN ORLANDO, FLORIDA WITH RESPECT TO ANY DISPUTE
ARISING UNDER THIS WARRANT, THE AGREEMENTS ENTERED INTO IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.
BOTH PARTIES IRREVOCABLY WAIVE THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH SUIT OR PROCEEDING. BOTH PARTIES
FURTHER AGREE THAT SERVICE OF PROCESS UPON A PARTY MAILED BY FIRST CLASS MAIL SHALL BE DEEMED IN EVERY RESPECT EFFECTIVE SERVICE
OF PROCESS UPON THE PARTY IN ANY SUCH SUIT OR PROCEEDING. NOTHING HEREIN SHALL AFFECT EITHER PARTY’S RIGHT TO SERVE PROCESS
IN ANY OTHER MANNER PERMITTED BY LAW. BOTH PARTIES AGREE THAT A FINAL NON-APPEALABLE JUDGMENT IN ANY SUCH SUIT OR PROCEEDING SHALL
BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON SUCH JUDGMENT OR IN ANY OTHER LAWFUL MANNER. THE PARTY WHICH
DOES NOT PREVAIL IN ANY DISPUTE ARISING UNDER THIS WARRANT SHALL BE RESPONSIBLE FOR ALL FEES AND EXPENSES, INCLUDING ATTORNEYS’
FEES, INCURRED BY THE PREVAILING PARTY IN CONNECTION WITH SUCH DISPUTE.

 

11.          Miscellaneous.

 

(a)          Amendments.
This Warrant and any provision hereof may only be amended by an instrument in writing signed by the Company and the Holder.

 

(b)          Descriptive
Headings. The descriptive headings of the several paragraphs of this Warrant are inserted for purposes of reference only,
and shall not affect the meaning or construction of any of the provisions hereof.

 

    	 	6	 

     

    

 

(c)          Remedies.
  The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder, by vitiating
the intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for
a breach of its obligations under this Warrant will be inadequate and agrees, in the event of a breach or threatened breach by
the Company of the provisions of this Warrant, that the Holder shall be entitled, in addition to all other available remedies at
law or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or
curing any breach of this Warrant and to enforce specifically the terms and provisions thereof, without the necessity of showing
economic loss and without any bond or other security being required.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    	 	7	 

     

    

 

IN WITNESS WHEREOF, the Company has
caused this Warrant to be signed by its duly authorized officer.

 

	 	ID GLOBAL SOLUTIONS CORPORATION
	 	 
	 	By:	 
	 	 	Thomas R. Szoke
	 	 	Chief Executive Officer
	 	 	 
	Dated as of April __, 2016	 	 

 

     

     

    

 

FORM OF EXERCISE AGREEMENT

 

Dated: ________ __, 20__

 

	To:	 	 

 

The undersigned, pursuant to the provisions
set forth in the within Warrant, hereby agrees to purchase ________ shares of Common Stock covered by such Warrant. The undersigned
intends that payment of the Exercise Price shall be made as (check one):

 

____ “cash exercise” in the
amount of $_________

 

____ “cashless exercise” pursuant
to Section 1 of the Warrant.

 

Please issue a certificate or certificates
for such shares of Common Stock in the name of and pay any cash for any fractional share to:

 

	 	Name:	 
	 	 	 
	 	Signature:	 
	 	Address:	 
	 	 	 
	 	 	 
	 	Note:	 	The above signature should correspond exactly with the name on the face of the within Warrant, if applicable.

 

     

     

    

 

FORM OF ASSIGNMENT

 

FOR VALUE RECEIVED,
the undersigned hereby sells, assigns, and transfers all the rights of the undersigned under the within Warrant, with respect to
the number of shares of Common Stock covered thereby set forth hereinbelow, to:

 

	Name of Assignee	 	Address	 	No of Shares	 
	 	 	 	 	 	 
	 	 	 	 	 	 
	 	 	 	 	 	 

 

, and hereby irrevocably constitutes and appoints ___________________________________
as agent and attorney-in-fact to transfer said Warrant on the books of the within-named corporation, with full power of substitution
in the premises.

 

	Dated: ________ __, 20__	 	 
	 	 	 
	In the presence of:	 	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Signature:	 
	 	Title of Signing Officer or Agent (if any):

 

	 	 	 
	 	Address:	 
	 	 	 
	 	 	 
	 		Note:	The above signature should correspond exactly with the name on the face of the within Warrant, if applicable.Converted by EDGARwiz

EXCLUSIVE LICENSE AGREEMENT

("Agreement")

Licensor:

CBI POLYMERS, INC. (a Delaware corporation)

Licensee:

ZEC, INC. (a Delaware corporation)

License Rights:

Licensee shall have the exclusive, world-wide right to manufacture, contract manufacture, market, sell, and distribute or sublicense DeconGel, PrestorPro and   all future products developed and/or acquired by Licensor ("Covered Products”).

All production agreements and any sublicense production agreements shall be

submitted to the Licensor for approval.

New products, new formulas of current products or package sizes may be added   to CBIP's line of products. Pricing for new products or package sizes are subject to change by the Licensor for a commercially reasonable basis and with at least thirty (30) days' notice to Licensee.

Sublicense Rights:

Sublicense agreements shall be submitted to the Licensor for approval. Such approval shall not be unreasonably withheld as long as the economic terms of the sublicense agreement to the   benefit of the   Licensor are economically consistent with this Agreement.

Transfer of Contracts:

All outstanding and pending marketing, sales and distribution relationships of Licensor for goods and/or services, to the extent transferable, shall be assigned to Licensee.

Know How:

Any and all applications techniques developed to date or in the future by Licensor are to be made available to Licensee.

Sale of Inventory:

Licensor agrees to sell to Licensee Licensor's existing product inventory at Licensor's fully loaded cost or at such price as may be agreed to by the parties.

Consideration:

Licensee agrees to pre -pay Licensor, in cash or other consideration, a sum equal to

$25,000 per month for the first 24 months of this Agreement for all rights related to existing products and services including those products and services under development as of the date of this Agreement.

Licensee further agrees to pay Licensor currently, in cash or other consideration, a sum equal to $10,000 per month during the term of this agreement for all rights related to future products and services not yet under development as of the date of this Agreement.

Royalty:

Licensee agrees to pay Licensor a royalty equal to the lesser of (a) ten percent (10%) of the revenue collected by Licensee (or by sub -licensee, if applicable) from the sale of all current and future products, or (b) $0.90 per liter on the sale of such products if applicable. Royalties shall be paid monthly in arrears within thirty (30) days of month's end.

Expenses:

Licensee shall bear the burden of its expenses of selling the Covered Products.

R & D:

Each party to this Agreement agrees to work with the other party to further product research and development.

Effective Date:

This Agreement shall be effective as of the date it is executed as set forth by the signatories below.

Tax Burden:

The Parties shall work together to minimize the tax burden in any of the above transactions.

Term:

This Agreement shall be for a term of two (2) years and shall be automatically renewable for nine (9) additional terms of two (2) years each provided that neither party is in breach of this Agreement. If either party is in breach the non- breaching party may extend this Agreement at its discretion.

Default:

If either party breaches any of the terms of this Agreement, the non -breaching party shall have the right to demand that the breaching party cure the breach

within a commercially reasonable period of time. If the breach is not cured within

a commercially reasonable period of time, the non -breaching party may seek any and all appropriate remedies including termination of this Agreement.

Notices:

Any notices or other communications  required  or permitted  under  this Agreement shall be sufficiently given if personally delivered to or sent by registered mail  or certified mail, postage prepaid, or by fax addressed as follows:

If to Licensor, to:

Jack Merbler, President CBI Polymers, Inc.

15110 Dallas Parkway, Suite 510

Dallas, TX 75248

If to Licensee, to:

E. Thomas Layton, Chairman & CEO ZEC, Inc.

1002 North Central Expressway, Suite 495

Richardson, TX 75080

Governing Law:

This Agreement will be governed by and construed, enforced, and interpreted in accordance with the internal and substantive laws of the State of Texas, without giving effect to principles of conflict of laws or the choice of law rules of any

jurisdiction other than the State of Texas.  The Parties agree to submit to the exclusive jurisdiction of the courts of the State of Texas and of the United States located in Dallas, Texas, and agree to waive, to the fullest extent permitted by law,  any objection to the laying of venue of any suit, action or proceeding arising out of

this license agreement in any such court.

LICENSOR:

CBI POLYMERS, INC.

a Delaware corporation

By:     /s/ Jack Merbler

Name:  Jack Merbler

  Title: President

LICENSEE: ZEC, INC.

a Delaware corporation

Date:  4/13/2016

By:     /s/ E. Thomas Layton

Date:  4/13/2016

Name: E. Thomas Layton Title:  Chairman & CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}]]